Morning Market Losers

By: via Benzinga
Puma Biotechnology (NYSE: PBYI) shares declined 18.47% to $62.31 after the company presented positive PB272 Phase II data at ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.